Axovant Gene Therapies Ltd. (AXGT) tumbled -5.2% or -0.06 to $1.19. It is approximately 2.72 million shares traded, which is 74.39% compare to the average total volume 3.66 million. The market cap of AXGT is $184.34 million. The year to date change is 10.01%. The 52 week price range is from $0.93 to $6.59. Price of AXGT have changed -6.02% during last week. It have changed 5.04% over last month, 8.70% over last 3 months, -35.23% over last 6 months and -14.38% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AXGT is 1.30. It is 9.24% above current price. The 200-day Moving Averages for AXGT is 1.83. It is 53.78% above current price. The 52-week High is 6.59. It is 453.78% from the current price. The 52-week Low is 0.93. It is -21.85% from current price.
There are some statistics of AXGT. It is has market cap $184.34 million. The share outstanding is 155.56 million. The average volume is 3.66 million. The percent of top 15 Institution holding is 21.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AXGT is -224.62%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AXGT is -99.35%.